Association of Tirofiban With Functional Outcomes After Thrombectomy in Acute Ischemic Stroke Due to Intracranial Atherosclerotic Disease.

Hongfei SangDongjing XieYan TianThanh N Nguyen Jeffrey L SaverRaul G NogueiraJunxiong WuChen LongZhenxuan TianZhizhou HuTao WangRongzong LiYingbing KeXiurong ZhuDaizhou PengMingze ChangLingfei LiJie RuanDeping WuWenjie ZiQing-Wu YangFengli LiZhong Ming Qiu

Published in: Neurology (2023)

In this post hoc analysis of the RESCUE BT trial, tirofiban was an effective and well-tolerated adjuvant medication of endovascular thrombectomy for patients with large vessel occlusion due to intracranial atherosclerosis. These findings need to be confirmed in future trials.

Keyphrases

acute ischemic stroke
optic nerve
early stage
study protocol
clinical trial
cardiovascular disease
healthcare
phase iii
current status
phase ii
randomized controlled trial
adverse drug
emergency department
open label
placebo controlled